Incidence of acne in patients with inflammatory bowel disease treated with Janus kinase inhibitors: a systematic review and meta-analysis
Acne is a common adverse event in IBD patients treated with JAK inhibitors. The reported incidence of acne was significantly higher with upadacitinib, in the pediatric population, and numerically higher during the induction phase of treatment.
Authors
- Maryam Alahmad
- Alex J. Vanni (ORCID: https://orcid.org/0000-0002-0755-0094)
- Thaer Khaleel Swaid
- Antonio Facciorusso
- Mohammed Nabil Quraishi
Institutions
- Alfaisal University (SA)
- University of Salento (IT)
- Khalifa University of Science and Technology (AE)
- King Faisal Specialist Hospital & Research Centre (SA)
- Yale University (US)
- Sheikh Shakhbout Medical City (AE)
- University of Birmingham (GB)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1093/ibd/izag032
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00